SFG
PFE icon

SNS Financial Group’s Pfizer PFE Stock Holding History

SNS Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-64,610
Closed -$2M – 212
2020
Q1 		$2M Sell
64,610
-3,584
-5% -$122K 0.38% 51
2019
Q4 		$2.54M Sell
68,194
-527
-0.8% -$18.8K 0.45% 42
2019
Q3 		$2.34M Buy
+68,721
New +$2.5M 0.45% 46
2017
Q2 		– Sell
-527
Closed -$17K – 196
2017
Q1 		$17K Buy
+527
New +$16.6K ﹤0.01% 198

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SNS Financial Group's PFE Position: Q1 2026 in Review

SNS Financial Group increased its Pfizer (PFE) stake by 0.13% in Q1 2026, buying an estimated $426 and bringing the position to 12,665 shares worth $356K. The position accounts for 0.03% of the portfolio, ranked #155.

SNS Financial Group first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $6.87M in Q4 2016. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SNS Financial Group held 12,665 shares of Pfizer worth $356K as of Q1 2026.
  • SNS Financial Group bought 16 Pfizer shares in Q1 2026, an estimated $426.
  • Pfizer made up 0.03% of SNS Financial Group's portfolio in Q1 2026, its #155 holding.
  • SNS Financial Group first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
  • SNS Financial Group's Pfizer position peaked at $6.87M in Q4 2016.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.